Triple-negative breast cancer (TNBC) is defined by the absence or very low expression of the two hormone receptors (HR) estrogen receptor (ER), and progesterone receptor (PR), and the absence of amplification of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and triple-negative breast carcinoma.